We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Ve Bionic Etf | LSE:CYBG | London | Exchange Traded Fund |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.075 | -0.44% | 16.968 | 16.874 | 17.064 | 17.076 | 16.957 | 17.076 | 219 | 16:35:09 |
TIDMCYBG TIDM11IO
RNS Number : 5824T
CYBG PLC
06 January 2017
CYBG PLC
(Company)
6 January 2017
Directorate Changes
The Company announces that Richard Gregory intends to retire as a Non-Executive Director on 10 January 2017. He will also retire as a Non-Executive Director of CYB Investments Limited and Clydesdale Bank PLC.
Richard joined the CYBG PLC group in March 2000 and is Senior Independent Non-Executive Director, Chair of the Board's Risk Committee, a member of the Board's Audit Committee and a member of the Board's Governance and Nomination Committee.
Jim Pettigrew, Chairman of the CYBG PLC Board said "On behalf of the Board I would like to thank Richard Gregory for his major contribution to the CYBG PLC group over a long period. Richard has been a very strong advocate of the Clydesdale and Yorkshire Bank brands during his extensive career and has brought considerable experience and insight to the Board. Richard played a key role in supporting the Board and management team during the Demerger from National Australia Bank Limited and the Initial Public Offering which was successfully completed last year. We wish him well for the future".
As a result of his retirement, Richard Gregory will not submit himself for re-election as a Director of the Company at the Company's Annual General Meeting on 31 January 2017 and resolution number 13 in the Notice of Annual General Meeting 2017 is therefore withdrawn.
David Bennett, Deputy Chairman will be appointed Senior Independent Non-Executive Director with effect from 11 January 2017. David joined the CYBG PLC group in October 2015. He is a member of the Board's Audit Committee, Board's Governance and Nomination Committee, Board's Risk Committee and Board's Remuneration Committee.
In addition, Clive Adamson will be appointed Chair of the Board's Risk Committee with effect 11 January 2017. Clive joined the CYBG PLC group in July 2016. He is a member of the Board's Audit Committee and Board's Risk Committee.
There are no other matters requiring disclosure under Listing Rule 9.6.13.
Enquiries
Investors and Analysts
John Crosse +44 7917 172535
Head of Investor Relations john.crosse@cybg.com
Hany Messieh +61 414 446 876
Investor Relations (Australia) hany.messieh@cybg.com
Company Secretary
Lorna McMillan 07834 585436
Company Secretary lorna.mcmillan@cybg.com
Media Relations
Press Office 0800 066 5998
press.office@cybg.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOABUGDBLXGBGRL
(END) Dow Jones Newswires
January 06, 2017 10:38 ET (15:38 GMT)
1 Year Ve Bionic Etf Chart |
1 Month Ve Bionic Etf Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions